Comparison of visual field progression between relatively low and high intraocular pressure groups in normal tension glaucoma patients

Journal of Glaucoma

Volumn 23, Issue 8, 2014, Pages 553-560

  Lee, Jeongmin ^a   Kong, Mingui ^a   Kim, Jaeryung ^a   Kee, Changwon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Intraocular pressure; Normal tension glaucoma; Progression; Risk factor; Visual field defect

Indexed keywords

BETAXOLOL; BRIMONIDINE; LATANOPROST;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTRAOCULAR HEMORRHAGE; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; LOW TENSION GLAUCOMA; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; RETROSPECTIVE STUDY; RISK FACTOR; VISUAL FIELD; VISUAL FIELD DEFECT; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL;

DISEASE PROGRESSION; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LOGISTIC MODELS; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; VISUAL FIELDS;

EID: 84916639953     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31829484c6     Document Type: Article

References (63)

1. Abedin S, Simmons RJ, Grant WM. Progressive low-Tension glaucoma: Treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure. Ophthalmology. 1982;89: 1-6.
2. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-Tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126: 487-497.
3. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-Tension glaucoma. Am J Ophthalmol. 1998;126: 498-505.
4. Anderson DR, Drance SM, Schulzer M. Natural history of normal-Tension glaucoma. Ophthalmology. 2001;108: 247-253.
5. Bhandari A, Crabb DP, Poinoosawmy D, et al. Effect of surgery on visual field progression in normal-Tension glaucoma. Ophthalmology. 1997;104: 1131-1137.
6. Cartwright MJ, Anderson DR. Correlation of asymmetric damage with asymmetric intraocular pressure in normaltension glaucoma (low-Tension glaucoma). Arch Ophthalmol. 1988;106: 898-900.
7. Crichton A, Drance SM, Douglas GR, et al. Unequal intraocular pressure and its relation to asymmetric visual field defects in low-Tension glaucoma. Ophthalmology. 1989;96: 1312-1314.
8. Brubaker RF. Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1996; 121: 473-483.
9. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120: 1268-1279.
10. Kaiser HJ, Flammer J. Systemic hypotension: A risk factor for glaucomatous damage? Ophthalmologica. 1991;203: 105-108.
11. Lin PW, Friedman M, Lin HC, et al. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma. 2011;20: 553-558.
12. Sergi M, Salerno DE, Rizzi M, et al. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma. 2007;16: 42-46.
13. Demailly P, Cambien F, Plouin PF, et al. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica. 1984;188: 65-75.
14. Drance SM, Sweeney VP, Morgan RW, et al. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 1973;89: 457-465.
15. Wang XH, Stewart WC, Jackson GJ. Differences in optic discs in low-Tension glaucoma patients with relatively low or high pressures. Acta Ophthalmol Scand. 1996;74: 364-367.
16. Yamagami J, Shirato S, Araie M. The influence of the intraocular pressure on the visual field of low tension glaucoma. Nihon Ganka Gakkai Zasshi. 1990;94: 514-518.
17. Kim DM, Seo JH, Kim SH, et al. Comparison of localized retinal nerve fiber layer defects between a low-Teen intraocular pressure group and a high-Teen intraocular pressure group in normal-Tension glaucoma patients. J Glaucoma. 2007;16: 293-296.
18. Chylack LT Jr, Wolfe JK, Singer DM, et al. The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol. 1993;111: 831-836.
19. Shirakashi M, Funaki S, Funaki H, et al. Measurement of retinal nerve fibre layer by scanning laser polarimetry and high pass resolution perimetry in normal tension glaucoma with relatively high or low intraocular pressure. Br J Ophthalmol. 1999;83: 353-357.
20. Anderson DR, Patella VM. Automated Static Perimetry. 2nd ed. Louis: Mosby; 1999.
21. Bengtsson B, Lindgren A, Heijl A, et al. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand. 1997;75: 184-188.
22. Leske MC, Heijl A, Hyman L, et al. Early Manifest Glaucoma Trial: Design and baseline data. Ophthalmology. 1999;106: 2144-2153.
23. Gherghel D, Orgul S, Gugleta K, et al. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol. 2000;130: 597-605.
24. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it-myth and reality. Prog Retin Eye Res. 2001; 20: 563-593.
25. Cox D. Regression models and life-Tables. J R Stat Soc Series B. 1972;34: 187-220.
26. Alison PD. Survival Analysis Using SAS: A Practical Guide. Cary, NC: SAS Publishing; 1995.
27. Leske MC, Heijl A, Hyman L, et al. Predictors of long-Term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114: 1965-1972.
28. Araie M, Sekine M, Suzuki Y, et al. Factors contributing to the progression of visual field damage in eyes with normal-Tension glaucoma. Ophthalmology. 1994;101: 1440-1444.
29. Ishida K, Yamamoto T, Sugiyama K, et al. Disk hemorrhage is a significantly negative prognostic factor in normal-Tension glaucoma. Am J Ophthalmol. 2000;129: 707-714.
30. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-Tension glaucoma. Am J Ophthalmol. 2001;131: 699-708.
31. Ishida K, Yamamoto T, Kitazawa Y. Clinical factors associated with progression of normal-Tension glaucoma. J Glaucoma. 1998;7: 372-377.
32. Daugeliene L, Yamamoto T, Kitazawa Y. Risk factors for visual field damage progression in normal-Tension glaucoma eyes. Graefes Arch Clin Exp Ophthalmol. 1999; 237: 105-108.
33. Yamamoto T, Iwase A, Kawase K, et al. Optic disc hemorrhages detected in a large-scale eye disease screening project. J Glaucoma. 2004;13: 356-360.
34. Iwata K. Primary open angle glaucoma and low tension glaucoma-pathogenesis and mechanism of optic nerve damage. Nihon Ganka Gakkai Zasshi. 1992;96: 1501-1531.
35. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38(suppl): S3-S6.
36. Grieshaber MC, Terhorst T, Flammer J. The pathogenesis of optic disc splinter haemorrhages: A new hypothesis. Acta Ophthalmol Scand. 2006;84: 62-68.
37. Begg IS, Drance SM, Sweeney VP. Ischaemic optic neuropathy in chronic simple glaucoma. Br J Ophthalmol. 1971;55: 73-90.
38. Raitta C, Sarmela T. Fluorescein angiography of the optic disc and the peripapillary area in chronic glaucoma. Acta Ophthalmol (Copenh). 1970;48: 303-308.
39. Jonas JB, Budde WM, Nemeth J, et al. Central retinal vessel trunk exit and location of glaucomatous parapapillary atrophy in glaucoma. Ophthalmology. 2001;108: 1059-1064.
40. Nakagami T, Yamazaki Y, Hayamizu F. Prognostic factors for progression of visual field damage in patients with normaltension glaucoma. Jpn J Ophthalmol. 2006;50: 38-43.
41. Ma KT, Kim CY, Seong GJ, et al. Intraocular pressure reduction in normal-Tension glaucoma patients in South Korea. Int Ophthalmol. 2011;31: 355-361.
42. Nakagami T, Yamazaki Y, Hayamizu F. Study on relationship between control of intraocular pressure and systemic risk factor for visual field progression in normal-Tension glaucoma. Nihon Ganka Gakkai Zasshi. 2010;114: 592-597.
43. Seong GJ, Rho SH, Kim CS, et al. Potential benefit of intraocular pressure reduction in normal-Tension glaucoma in South Korea. J Ocul Pharmacol Ther. 2009;25: 91-96.
44. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-Angle glaucoma. Arch Ophthalmol. 2002;120: 701-713; discussion 829-830.
45. Rao HL, Kumar AU, Babu JG, et al. Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma. Ophthalmology. 2011;118: 249-253.
46. Chihara E, Liu X, Dong J, et al. Severe myopia as a risk factor for progressive visual field loss in primary open-Angle glaucoma. Ophthalmologica. 1997;211: 66-71.
47. Sohn SW, Song JS, Kee C. Influence of the extent of myopia on the progression of normal-Tension glaucoma. Am J Ophthalmol. 2010;149: 831-838.
48. Kim C, Kim TW. Comparison of risk factors for bilateral and unilateral eye involvement in normal-Tension glaucoma. Invest Ophthalmol Vis Sci. 2009;50: 1215-1220.
49. Leske MC, Wu SY, Hennis A, et al. Risk factors for incident open-Angle glaucoma: The Barbados Eye Studies. Ophthalmology. 2008;115: 85-93.
50. Tielsch JM, Katz J, Sommer A, et al. Hypertension, perfusion pressure, and primary open-Angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995;113: 216-221.
51. De Moraes CG, Juthani VJ, Liebmann JM, et al. Risk factors for visual field progression in treated glaucoma. Arch Ophthalmol. 2011;129: 562-568.
52. Ahrlich KG, De Moraes CG, Teng CC, et al. Visual field progression differences between normal-Tension and exfoliative high-Tension glaucoma. Invest Ophthalmol Vis Sci. 2010; 51: 1458-1463.
53. Aoyama A, Ishida K, Sawada A, et al. Target intraocular pressure for stability of visual field loss progression in normaltension glaucoma. Jpn J Ophthalmol. 2010;54: 117-123.
54. Fontana L, Viswanathan AC, Poinooswamy D, et al. Surgery for normal tension glaucoma. Target intraocular pressure and visual field progression. Acta Ophthalmol Scand Suppl. 1997;75(suppl): 43-44.
55. Hitchings RA, Wu J, Poinoosawmy D, et al. Surgery for normal tension glaucoma. Br J Ophthalmol. 1995;79: 402-406.
56. Daugeliene L, Yamamoto T, Kitazawa Y. Effect of trabeculectomy on visual field in progressive normal-Tension glaucoma. Jpn J Ophthalmol. 1998;42: 286-292.
57. Shigeeda T, Tomidokoro A, Araie M, et al. Long-Term follow-up of visual field progression after trabeculectomy in progressive normal-Tension glaucoma. Ophthalmology. 2002;109: 766-770.
58. Gramer E, Leydhecker W. Glaucoma without ocular hypertension. A clinical study. Klin Monbl Augenheilkd. 1985; 186: 262-267.
59. David R, Zangwill L, Stone D, et al. Epidemiology of intraocular pressure in a population screened for glaucoma. Br J Ophthalmol. 1987;71: 766-771.
60. Suzuki Y, Iwase A, Araie M, et al. Risk factors for open-Angle glaucoma in a Japanese population: The Tajimi Study. Ophthalmology. 2006;113: 1613-1617.
61. Hashemi H, Kashi AH, Fotouhi A, et al. Distribution of intraocular pressure in healthy Iranian individuals: The Tehran Eye Study. Br J Ophthalmol. 2005;89: 652-657.
62. Suh W, Kee C. The distribution of intraocular pressure in urban and in rural populations: The Namil study in South Korea. Am J Ophthalmol. 2012;154: 99-106.
63. Kim CS, Seong GJ, Lee NH, et al. Prevalence of primary openangle glaucoma in central South Korea the Namil study. Ophthalmology. 2011;118: 1024-1030.